Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.000 | 100.000 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.133 | 21.748 |
Price to Book | 6.326 | 4.013 |
Price to Sales | 1.958 | 2.262 |
Price to Cash Flow | 19.506 | 16.964 |
Dividend Yield | 1.351 | 1.339 |
5 Years Earnings Growth | 8.571 | 11.136 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.150 | 94.942 |
Basic Materials | 0.560 | 1.277 |
Consumer Defensive | 0.290 | 3.344 |
Number of long holdings: 42
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly and Co | - | 8.21 | - | - | |
Novo Nordisk B | DK0062498333 | 7.97 | 850.6 | -2.58% | |
UnitedHealth Group Inc | - | 7.46 | - | - | |
Merck & Co Inc | - | 6.04 | - | - | |
Roche Holding Participation | CH0012032048 | 4.92 | 217.30 | +1.49% | |
GSK plc | GB00BN7SWP63 | 4.69 | 1,733.50 | +0.29% | |
Regeneron Pharmaceuticals Inc | - | 4.62 | - | - | |
Elevance Health Inc | - | 4.28 | - | - | |
Vertex Pharmaceuticals Inc | - | 4.27 | - | - | |
Amgen Inc | - | 4.18 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
American Growth Portfolio C Acs | 7.85B | 13.06 | 9.86 | 14.34 | ||
Thematic Research Portfolio S SGD A | 6.44B | 8.29 | 20.72 | 12.07 | ||
American Growth Portfolio A Acs | 7.11B | -25.83 | 11.14 | 14.09 | ||
Thematic Research Portfolio SX Accs | 3.45B | 10.51 | 22.54 | 12.86 | ||
Thematic Research Portfolio S1X Acs | 2.74B | 10.14 | 21.69 | 12.12 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review